• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Lifetime Smoking and its Impact on Risk for Lung Cancer and Cardiovascular Disease: Results from the Framingham Heart Study

    Duncan, Meredith Stevenson
    0000-0001-6922-8503
    : http://hdl.handle.net/1803/16105
    : 2020-07-17

    Abstract

    Among Framingham Heart Study (FHS) participants who smoked at least 20 pack-years, former heavy smokers’ risk of ASCVD and lung cancer may persist for up to 16 and beyond 25 years since quitting, respectively, compared to those who never smoke. Currently, American Heart Association/American College of Cardiology (AHA/ACC) ASCVD risk calculators assume former smokers quit >5 years have the same ASCVD risk as never smokers. Thus, former smokers’ ASCVD risk may be underestimated by such tools. Furthermore, despite their elevated risk, most heavy ever smokers never develop lung cancer while some never smokers do develop lung cancer; this may suggest a gene-by-smoking interaction. To fill these gaps in knowledge, we used longitudinal data from FHS to: 1 – assess the added value of incorporating pack-years smoked and years since quitting into ASCVD risk prediction models; and 2 – determine whether there is a gene-by-smoking interaction on lung cancer risk and explore whether a polygenic risk score (PRS) could be used to distinguish which ever smokers develop lung cancer outside of the current screening guidelines. Adding pack-years smoked and years since quitting to the current AHA/ACC ASCVD risk calculator had significant but modest continuous net reclassification improvement (NRI(>0)) and relative integrated discrimination improvement (rIDI) values in both sexes (Men: NRI(>0)=0.23, rIDI=0.19; Women: NRI(>0)=0.34, rIDI=0.11). In lung cancer analyses, we observed significant effect modification between the PRS and pack-years smoked on lung cancer risk such that the relative effect of pack-years smoked decreased with increasing PRS. We observed no significant association between the PRS and meeting lung cancer screening eligibility at time of diagnosis. Our results have important implications for clinical practice and suggest that pack-years smoked and years since quitting smoking should be incorporated into 10-year ASCVD risk estimation and that future research should focus on the impact of genetic burden and its interaction with pack-years smoked when assessing lung cancer risk.
    Show full item record

    Files in this item

    Icon
    Name:
    DUNCAN-DISSERTATION-2020.pdf
    Size:
    1.194Mb
    Format:
    PDF
    View/Open
    Name:
    Duncan, Meredith-Dissertation- ...
    Size:
    778.6Kb
    Format:
    Microsoft Word 2007
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy